Delivery Order SPE2DB22D1106-SPE2DB24FFFG4
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.58, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML pharmaceutical products. The $3,620.88 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 26, 2024. The contract does not have a set-aside designation. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen has significant experience...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,731.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,943.70 firm fixed-price contract is for the delivery of 250 mcg/0.5 ml syringes of the medication Ovidrel, with a completion date of May 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
The federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies, with a ceiling value of $3,501.50. The contract was awarded on June 6, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 9, 2025 and is a firm fixed-price delivery order. The contract is not set-aside and is an open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $3,585.48 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $1,329.89, was issued by the Medical Supply Chain division of the U.S. Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564677408 ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of June 12, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $2,974.38 for the provision of pharmaceutical products and medical supplies to the Department of Defense's Medical Supply Chain. The contract has an ultimate completion date of May 10, 2024 and is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, involves the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other government agencies. The contract, valued at up to $4,392.66, is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to...